Pfizer has submitted an application for emergency use authorization for its COVID-19 vaccine in children between the ages of 5 and 11 years old. The news has come as a relief for some parents who have worried about their children’s exposure in school.
There was prospectively encouraging news for parents on Thursday when Pfizer and German partner BioNTech said they had submitted an application for emergency-use authorization of their COVID-19 vaccine in 5- to 11-year-old children.
Experts and White House officials continue to urge unvaccinated people to get their shots, as those who have not been vaccinated account for the majority of cases and deaths. The U.S. has fully vaccinated abut 56% of its overall population, according to the CDC’s vaccine tracker, a number that has remained nearly static for weeks.
The news comes after the White House said it would spend $1 billion on rapid, at-home tests to boost the nation’s testing program. “The risk of such loss was 1.1 to 4.5 times higher among children of racial and ethnic minorities, compared to non-Hispanic White children,” the authors wrote. “The highest burden of COVID-19-associated death of parents and caregivers
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer, BioNTech ask FDA to authorize Covid-19 vaccine for kids 5-11The filing could clear the way for roughly 28 million children in the United States to be vaccinated against the virus, beginning in a matter of weeks.
Read more »
Pfizer seeks FDA authorization of Covid-19 vaccine for children ages 5 to 11Pfizer and BioNTech said Thursday they are seeking US Food and Drug Administration emergency use authorization from for their Covid-19 vaccine for children ages 5 to 11.
Read more »
Pfizer Asks US To Allow COVID Shots For Kids Ages 5 To 11Pfizer is asking the U.S. government to allow use of its COVID-19 vaccine in children ages 5 to 11.
Read more »